clinical trial · NCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Primary Hyperoxaluria Type 1
brief summary
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
started
Dec 13, 2021
primary completion
Jan 2, 2029
completion
Jan 2, 2029
last updated
Sep 8, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol